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Abstract.  A  pepsin-resistant triple helical domain 
(chain 50,000 Mr) of type VIII collagen was isolated 
from bovine corneal Descemet's membrane and used 
as an immunogen for the production of mAbs.  An an- 
tibody was selected for biochemical and tissue im- 
munofluorescence studies which reacted both with 
Descemet's membrane and with type VIII collagen 
50,000-Mr  polypeptides by competition ELISA and 
immunoblotting.  This antibody exhibited no cross- 
reactivity with collagen types I-VI by competition 
ELISA. 
The mAb specifically precipitated a high molecular 
mass component of type VIII collagen (EC2,  of chain 
125,000  Mr) from the culture medium of subconfluent 
bovine corneal endothelial cells metabolically labeled 
for 24 h.  In contrast,  confluent cells in the presence of 
FCS and isotope for 7 d  secreted a collagenous com- 
ponent of chain 60,000 Mr that did not react with the 
anti-type VIII collagen IgG.  Type VIII collagen there- 
fore appears to be synthesized as a discontinuous tri- 
ple helical molecule with a predominant chain  125,000 
Mr by subconfluent, proliferating  cells in culture. 
Immunofluorescence studies with the mAb showed 
that type VIII collagen was deposited as fibrils in the 
extracellular matrix of corneal endothelial cells.  In the 
fetal calf, type VIII collagen was absent from base- 
ment membranes and was found in a  limited number 
of tissues.  In addition to the linear staining pattern ob- 
served in the Descemet's membrane, type VIII colla- 
gen was found in highly fibrillar arrays in the ocular 
sclera,  in the meninges surrounding brain,  spinal cord, 
and optic nerve, and in periosteum and perichondrium. 
Fine fibrils were evident in the white matter of spinal 
cord, whereas a more generalized staining was appar- 
ent in the matrices of cartilage and bone. Despite at- 
tempts to unmask the epitope, type VIII collagen was 
not found in aorta,  kidney, lung,  liver, skin,  and liga- 
ment.  We conclude that this unusual collagen is a 
component of certain specialized extracellular ma- 
trices,  several of which are derived from the neural 
crest. 
T 
YPE VIII collagen  was first isolated  from the culture 
medium of metabolically labeled bovine aortic endo- 
thelial  cells (22, 24).  This  collagen  was termed EC 
(endothelial collagen) and a survey of its distribution  showed 
that it was secreted in limited amounts by most cultured bo- 
vine vascular and corneal endothelial  cells and  by human 
fibroblasts  (21). Type VIII collagen  was also produced in 
somewhat larger amounts by cell lines derived from a human 
astrocytoma  (1), Ewing's  sarcoma  (of  the  femur),  and 
adenocarcinomas metastatic  to bone and pelvis (21). Since 
most studies on type VIII collagen to date have been carried 
out in cell culture systems  or with Descemet's membrane 
(DMt; a specialized  extracellular  matrix  [ECM]  subjacent 
I. Abbreviations used in this paper: BCE, bovine corneal endothelial; DM, 
Descemet's membrane; ECM,  extracellular matrix; RCE,  rabbit corneal 
endothelial. 
to the corneal endothelium),  the general  distribution  of this 
collagen  in tissues is not known. 
Studies in vitro have suggested that native type VIII colla- 
gen consists  of pepsin-resistant,  triple-helical  collagenous 
domains  (chain  50.000  Mr)  linked  in  tandem  by noncol- 
lagenous  domains of Mr <  10,000 that  compose the major 
secreted products of chain  177,000 Mr (EC1) and 125,000 Mr 
(EC2; see reference 20 for a review of this "cassette" model). 
Recently,  pepsin-resistant  collagenous  fragments  (Mr  = 
50 kD) isolated from bovine corneal DM have been shown 
to be derived from type VIII collagen  (11). Rabbit antisera 
specifically  reactive with the pepsin-resistant  fragments  ex- 
tracted  from tissue have been used to demonstrate the im- 
munological  identity  of the tissue fragments  with the type 
VIII chain,  EC2, synthesized  by bovine corneal endothelial 
(BCE) cells. These polyclonal antibodies have also localized 
type VIII collagen  to DM.  Benya and Padilla  (3), using  a 
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from the culture medium of endothelial cells, have proposed 
an alternate model in which type VIII collagen was com- 
prised of a triple helix of chain 61,000 Mr. 
In the present study we have generated mAbs specific for 
the pepsin-resistant, triple-helical domains of type VIII col- 
lagen. We present evidence that the secreted form of type 
VIII collagen is EC2 of chain 125,000 Mr, and we show that 
type VIII collagen is located in the ECM of BCE cells in 
vitro. The tissue distribution of type VIII collagen in fetal bo- 
vine tissues was found to be restricted to specialized connec- 
tive tissue matrices, including perichondrium, periosteum, 
and cartilage. In addition, several  structures of neural crest 
origin, such as calvarium, DM, ocular sclera, and meningial 
coverings contained significant amounts of this unusual col- 
lagen. 
Materials and,Methods 
Isolation of  CoUagens  from DM and Perichondrium 
Frozen  adult  bovine  eyes  were  obtained  from  PeI-Freeze  Biologicals 
(Rogers, AR). Collagens were isolated by a short pepsin digestion of DM, 
followed by salt fractionation as previously described by Kapoor et al (1 I). 
Bovine trachea, obtained from a local slaughterhouse, was rinsed and trans- 
ported at 0°C in PBS containing 0.1 M e-amino caproic acid, 0.1 M EDTA, 
5  mM N-ethylmaleimide, 5  mM benzamidine hydrochloride, and  1 mM 
PhCH2-SO~E ~  connective tissue adhering to the trachea was removed, 
and  the  perichondrium was  peeled from  the  underlying cartilage.  The 
perichondrium was sliced into small pieces (*1 mm3), washed with deter- 
gent/DNase (4), and digested with pepsin. The coilagenous proteins were 
subsequently fractionated by differential precipitation in NaCI  (11). 
Cell Culture and Metabolic Labeling 
Primary cultures of BCE cells were prepared by modifications of the method 
described by MacCallum et al. 08). Fresh adult bovine eyes from a local 
slaughterhouse were transported in cold PBS containing 200 I.tg/ml each of 
streptomycin and penicillin G. 6-10 eyes were used for each primary cul- 
ture. After a thorough wash under running tap water, the corneal side of  each 
orbit was liberally rinsed with 70% ethanol followed immediately by PBS. 
The corneas were then excised and sequentially rinsed in four dishes con- 
taining serum-free DME with 5 p,g/ml Amphotericin B, and 50 lag/ml Gen- 
tamycin in addition to penicillin/streptomycin. Corneas were placed, en- 
dothelial side up, in a petri dish.  15-mm rings cut from stainless steel pipe 
and dipped in sterile silicon grease were set firmly onto each cornea to cre- 
ate a well for trypsinizing the cells. The endothelium was rinsed twice with 
0.02 % EDTA in PBS and incubated at 37°C in a solution of  2.5 % trypsin/1% 
EDTA (Gibco, Grand Island, NY) for 5 min. Cells were removed by gently 
pipetting up and down and rinsing with DME containing 16% FCS and anti- 
biotics. The cell suspension was plated into a 35-mm tissue culture dish and 
allowed to attach for 3-4 h before the media were changed. Cultures were 
maintained in DME containing 16% serum and passaged at a 1:3 subcultiva- 
tion ratio. The results presented are from subcultures in the third and fifth 
passage. 
Metabolic  labeling  of cells  with  L-12,3,4,5-3H]proline  (100  Ci/mol; 
Amersham  Corp.,  Arlington  Heights,  IL)  was  carried  out  on  nearly 
confluent cells as described by Sage et al. (22). Proteins including type VIII 
collagen were subsequently isolated from the culture medium by ammo- 
nium sulfate precipitation and DEAE-cellulose chromatography (24). 
Confluent cultures of BCE and rabbit corneal endothelial cells (RCE) 
were labeled in DME containing 2 % FBS, 25 lag/ml sodium ascorbate, 62.5 
p.g/ml 13-aminopropionitrile,  and 50 I.tCi/ml L-[2,3-3H]proline  (35 Ci/mol). 
The medium was collected daily and  replaced with fresh medium (sup- 
plemented as above) for 7 d. This postculture medium was adjusted to the 
following buffer and protease inhibitor concentrations: 50 mM Tris-HCI, 
pH 8, 20 mM N-ethylmaleimide, 10 mM e-aminocaproic acid, 10 mM ben- 
zamidine hydrochloride, 10 mM EDTA,  1 mM PhCH2SO2F, 0.23 TIU/ml 
aprotinin (Sigma A-6012), and  10 p.g/ml each of leupeptin, antipain, and 
chymostatin (Sigma Chemical Co., St. Louis, MO). After centrifugation to 
remove cellular debris, the medium was stored at  -20°C.  The type VIII 
collagen was subsequently isolated from the pooled media by a combination 
of ultrafiltration, sucrose density gradient sedimentation, salt fractionation, 
and  ion-exchange chromatography,  exactly  as  described by  Benya  and 
Padilla (3). 
Production of mAbs 
A.Sw/J mice (Jackson Labora~ry, Bar Harbor, ME) were immunized with 
the pepsin-resistant fragments of type VIII collagen, and their splenic lym- 
phocytes were fused with the myeloma cell line P3-NS1/1-Ag4-1 (14) accord- 
ing to previously described methods (25, 26).  Hybridomas were screened 
for the production of specific antibody by ELISA (5) and by indirect im- 
munofluorescence. Antibody was collected from selected hybridoma clones 
either as spent culture supernate or as ascites from Balb/c  x  ASw hybrid 
mice. These animals had been primed with pristane and injected with a 
minimum of 107 hybridoma cells. 
Immunoblotting and ELISA 
SDS-PAGE was performed according to Laemmli (16) on polyacrylamide 
slab gels containing 0.5 M urea, and proteins were transferred to nitrocellu- 
lose sheets. Immunoblotting was carried out according to Towbin et al. (30), 
as modified by Kapoor et al. (11). ELISA was performed on microtiter plates 
coated with 1-5 ~,g antigen. Inhibition of binding was tested by mixing anti- 
body, diluted to the concentration that produced one-half  the maximal bind- 
ing, with inhibitor at various concentrations for 12 h at 4"C, Digestion of 
the antigen by bacterial collagenase before ELISA was performed as de- 
scribed (25). 
lmmunoprecipitation and AJ~inity Chromatography 
Culture medium proteins were obtained from metabolically labeled BCE 
cells by ammonium sulfate precipitation and DEAE-cellulose chromatogra- 
phy. The unbound chromatographic fraction was dialyzed against 0.1 M ace- 
tic acid at 4°C and lyophilized. It was then dissolved in 2 ml of PBS, pH 
7.4, and divided into twa equal parts. To one part, 100 I.tl of polyclonal anti- 
bodies, afffinity-purified against the pepsin-resistant fragments of type VIII 
collagen (11), was added, and to the other part 100 I.tl of the mAbs was added. 
The mixtures were shaken gently overnight at 4°C.  Subsequently, 100 p.l 
of Protein  A-Sepharose (Pharmacia  Fine  Chemicals,  Piscataway,  NJ), 
washed in a solution of BSA to block nonspecific binding and resuspended 
in 150 mM NaCI, 5 mM EDTA, and 50 mM Tris-HCI at pH 7.4, was added 
to each tube. The mixtures were shaken gently at room temperature  for 2-3 h 
and subsequently centrifuged (microfuge). The pellet was washed with the 
same buffer and centrifuged for 3 min. This procedure was repeated five 
times. Finally,  the pellet was dissolved in 50 ~1 of Laemmli buffer (16), 
heated at 100°C for 2-3 min, and centrifuged for 3 min. The supernate was 
analyzed by electrophoresis on an 8% polyacrylamide gel. 
The mAb was coupled to CNBr-activated Sepharose according to the 
manufacturer's instructions. Proteins, isolated from the culture medium of 
metabolically labeled BCE cells, were dissolved in 0.5-1.0 ml of PBS and 
equilibrated with the affinity  resin for 30 min at 4°C. The eluate was re- 
chromatographed three times, and the column was washed extensively with 
PBS until  the radioactive counts returned to background level. The bound 
protein was then eluted with 0.02 M HCl/glycine (pH 2.2). A peak of radio- 
activity  was  collected, dialyzed against 0.1  M  acetic  acid at  4°C,  and 
lyophilized. 
lmmunofluorescence Microscopy 
Although several calves representing a broad spectrum of fetal age were ex- 
amined, tissue sections used in this study were taken from a single fetal calf 
that measured •1  foot 5 inches from crown to rump. The animal was ob- 
tained at a local slaughterhouse shortly after removal from the mother. The 
estimated age of  this fetus was 140 d, a stage of  development  before the onset 
of  extensive ossification. Tissues were dissected and frozen in hexane in liq- 
uid nitrogen. Eight micron sections were cut using a histostat microtome 
(American Optics, Buffalo,  NY) at -28°C. Sections were air dried for 30 
min and fixed in cold acetone for 10 min. mAb (ascites) diluted I:100 with 
PBS was incubated with the sections for 3 h at room temperature. After 
a  wash  with  PBS,  FITC-conjugated  anti-mouse IgG  (Sigma  Chemical 
Co.), diluted 1:50 with PBS, was incubated with the sections for 30 min. 
Slides were then washed several times with PBS, and the sections were cov- 
ered with 90% glycerol in PBS. Photographs were taken with a Zeiss Pho- 
tomicroscope III. 
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chemicals, Freehold, NJ), at a concentration of 8,000 U/ml in 0.1 M phos- 
phate buffer, pH 5.3, for 20 min at room temperature. Alternatively,  sections 
were exposed to pepsin (0.1 mg/ml; Boehringer Mannbeim GmbH, Mann- 
heim, Federal Republic  of  Germany) in 0.1 M acetic acid for 10 rain at room 
temperature, or to 0.1 M acetic acid at room temperature for 30 rain. The 
sections were washed with PBS and prepared for immunofluorescence  mi- 
croscopy. 
BCE cells were carefully isolated with 0.025% trypsin (Sigma Chemical 
Co.) from freshly dissected eyes. Cells were grown on chamber slides in 
DME, supplemented with 10% FIBS  and penicillin/streptomycin  (Gibco). 
Cells were washed with PBS, fixed in cold acetone for 10 min, and stained 
as described above. Alternatively, for experiments with rabbit polyclonal 
antibodies, cells were grown on  glass coverslips and fixed in buffered 
paraformaldehyde  (3%) as described by Sage et al. (23), except that cells 
were not permeabilized before incubation with antibodies. For staining un- 
fixed  cells, the cells were preincubated  in medium without serum for 30 min 
at 37°C, washed twice with PBS for 10 rain each, and incubated with pri- 
mary antibody for 90 min at room temperature. The cells were then washed 
with serum-free medium for 10 min, rinsed twice with PBS, and incubated 
with FITC-conjugated  goat anti-rabbit IgG (Sigma Chemical Co.) for 30 
min. Cells were washed twice with PBS and were then fixed in 3 % parafor- 
maldehyde for 30 min. The coverslips were washed three times with PBS 
and mounted on glass slides. To analyze the extracellular matrix, the cells 
were removed from the coverslips by treatment with 0.1% Triton X-100 for 
2-5 min at 37°C. Polyclonal  antibodies affinity-purified  against bovine type 
III procollagen have been described by Sage et al. (23). 
Results 
Characterization of  Anti-type VIII Collagen mAb 
Hybridoma culture wells were first screened by ELISA for 
binding to the original immunogen, a native preparation con- 
raining the pepsin-resistant domains of bovine type V  and 
type VIII collagens. Supernatant media which were positive 
by  ELISA were  then  tested  by  immunofluorescence.  Two 
wells contained antibody that stained DM.  Further analysis 
by immunoblotting showed that one of the clones (an IgG) 
secreted antibody which reacted specifically with the 50-kD 
pepsin-resistant fragments of type VIII collagen. This clone 
was selected for the present study. 
ELISA reactivity with  the  pepsin-resistant fragments of 
type VIII collagen could be inhibited by prior incubation of 
the fragments with a dilution of ascites mAb, but this binding 
could not be inhibited by incubation with types I, III, IV, V, 
and VI collagens (Fig.  1).  The epitope on type VIII (50-kD 
fragments) was, however,  sensitive to bacterial collagenase 
(data  not  shown).  This  antibody  also  reacted  with  both 
chicken and human type VIII collagen. 
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Figure  1.  Characterization 
of  monoclonal  antibody  by 
ELISA. Microtiter plates were 
coated with 5  lag of 50,000- 
Mr collagenous fragments  of 
type VIII collagen dissolved 
in 0.1  M  Na2CO3 buffer,  pH 
8.  Competition  ELISA  with 
mAbs  (1:10,000)  was  carried 
out by incubation with varying 
concentrations of antigens at 
4°C  for 24 h.  (e) 50,000-Mr 
fragments of type VIII colla- 
gen; (e) collagen types I, III, 
IV, V, and VI. 
Figure 2. Immunoisolation  of  type VIH collagen by monoclonal and 
affinity purified polyclonal anti-50,000-Mr IgG. Type VIII colla- 
gen was isolated from the culture medium of [3H]proline-labeled 
BCE cells. Proteins that were not bound by DEAE-cellulose were 
dialyzed against 0.5 M acetic acid at 4°C and lyophilized. Aliquots 
of this  material were  immunoprecipitated with monoclonal and 
polyclonal antibodies and  were  subsequently analyzed by  SDS- 
PAGE on an 8% gel. Lane 1, total fraction; lane 2, immunoprecipi- 
tation with polyclonal anti-50,000-Mr IgG (band represents 11.1% 
of input cpm); lane 3, immunoprecipitation with monoclonal anti- 
50,000-Mr  IgG (3.6%  of input cpm).  Alternatively, BCE culture 
medium proteins were chromatographed over an affinity column of 
monoclonal  anti-50,000-M~  IgG coupled  to  Sepharose,  and  the 
bound proteins were eluted with 0.02 M glycine, pH 2.2 (lane 4). 
Lane 5, lane 4 before reduction with dithiothreitol (DTT). Molecu- 
lar mass  standards of globular proteins shown  on the right are 
200,000,  94,000,  68,000,  and 43,000  D. EC1,  2, and 3 denote the 
chains of type VIII collagen, with M~ of 180,000, 125,000, and 
100,000, respectively. 
Immunologic and Biosynthetic Studies: Evidence 
for the Cassette Model 
Proteins were fractionated from the culture medium of meta- 
bolically  labeled BCE  cells.  Analysis  by  SDS-PAGE  re- 
vealed the EC1, EC2, and EC3 chains of type VIII collagen 
(Fig. 2,  lane 1);  these components were degraded by bac- 
terial collagenase (results not shown).  EC2 was specifically 
precipitated by the mAb and by affinity-purified polyclonal 
antibodies against the 50,000-Mr fragments of type VIII col- 
lagen (Fig. 2, lanes 2 and 3). This finding was confirmed by 
affinity purification of type VIII collagen from the culture 
medium of BCE cells by adsorption to mAb-Sepharose. The 
proteins bound to the affinity column were eluted in a  peak 
that represented  1.0%  of the original counts applied to the 
column. SDS-PAGE showed a single band corresponding to 
EC2 which was unaffected by disulfide bond reduction (Fig. 
2,  lanes 4  and 5). 
Since both preparations of antibodies precipitated a  type 
VIII collagen chain of Mr >  60,000,  we examined the effect 
of culture  conditions  on  the  initial molecular  size  of the 
secreted protein.  Type VIII collagen was purified from the 
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trix as a function of  time in culture. After 12 d, fibrillar stain- 
ing was seen in various regions of the slide (Fig. 4 A). After 
34 d in culture, immunofluorescent fibers were more abun- 
dant (Fig. 4 B). Accumulation type VIII collagen in the cell 
layer as a  function of time provides an explanation for its 
depletion from the culture medium.  The fibrillar staining 
patterns of  type VIII collagen, demonstrated for comparative 
purposes with affinity-purified polyclonal antibodies raised 
against the 50,000-Mr  fragments in Fig.  4,  D  and F,  were 
less dense than those observed for type III collagen (Fig. 4, C 
and  E).  Similar patterns  were obtained whether the cells 
were  fixed  in  paraformaldehyde  (not  shown),  were  first 
stained live and then fixed in paraformaldehyde (Fig. 4,  C 
and D), or were first removed with 0.1% Triton X-100 and 
the underlying matrix stained (Fig. 4, E and F). No staining 
of the cells or matrix was seen when preimmune serum was 
used (data not shown). 
Figure 3. Analysis of type VIII collagen isolated from the culture 
medium of BCE and RCE cells. Subconfluent and confluent BCE 
and RCE cells were incubated with [aH]proline for 24 h and 7 d. 
Proteins were resolved on an 8% SDS gel under reducing condi- 
tions and were visualized by fluorescence autoradiography. Lanes 
I and 2, subconfluent BCE and RCE cells, respectively, labeled for 
24 h; lanes 3 and 4, confluent BCE and RCE cells, respectively, 
labeled for 7 d. The arrow indicates a protein of ,x,60,000 Mr that 
accumulated in the cell culture medium during the 7-d labeling 
period. 
culture medium of subconfluent and fully confluent RCE and 
BCE cells. EC1, EC2, and EC3 could be demonstrated in the 
culture medium of subconfluent BCE cells after a 24-h label- 
ing period (Fig. 3, lane 1). EC1 and EC2 were also present 
in the culture medium of subconfluent RCE cells (Fig. 3, lane 
2). Labeling of fully confluent cells for longer periods (7 d) 
resulted in a reduction of the amount of EC2, and a loss of 
EC1 and EC3, from the culture media of both RCE and BCE 
cells (Fig. 3, lanes 3 and 4). In addition, a protein with an 
approximate Mr of 60,000 was apparent in the culture media 
of these cells (Fig. 3, lanes 1-4, arrow). This protein did not 
cross  react  with  anti-50,000-Mr  IgG  by  Western  blotting 
(results not shown). Furthermore, in all the experiments in 
which we have exposed BCE culture media to monoclonal 
or polyclonal anti-type VIII collagen IgG, we have not ob- 
served reactivity with a component of 60,000 Mr. We there- 
fore suggest that under conditions of  prolonged culture in the 
presence of serum, corneal endothelial cells modulate colla- 
gen synthesis and switch to the production of the 60-kD col- 
lagen previously described by Benya and Padilla (3). 
Immunofluorescence In Vitro 
Immunofluorescence studies of BCE cells in culture showed 
Distribution of 7)~pe VIII Collagen In l/Do 
Tissues from a single calf (estimated age was  140 d) were 
selected  for  immunofluorescence  examination  using  the 
anti-type VIII collagen mAb..There was linear staining of 
DM in the cornea, but no fluorescence in the stroma or Bow- 
man's membrane (Fig. 5 a). In the surrounding sclera (Fig. 
5 c), type VIII appeared highly fibrillar and resembled fibril- 
lin, a constitutive structural element of extracellular micro- 
fibrils (26).  Staining  with an mAb  specific for fibrillin is 
shown for comparison, in Fig. 5, b and d. Type VIII collagen 
immunofluorescence also clearly defined the corneal-scleral 
junction (data not shown). 
While the staining pattern of type VIII collagen in DM and 
sclera seemed similar to that of fibrillin, the distribution of 
type VIII was highly restricted. Bundles of fibrillin gave a 
dispersed fibrillar staining in the corneal stroma as well as 
a linear staining of DM (Fig. 5 b), and there was significant 
staining of the sclera (Fig.  5 d).  Fibrillin was present as a 
major component of aorta (Fig. 5 f) and of nuchal ligament 
(Fig. 5 h), while type VIII appeared to be absent from aorta 
(Fig. 5 e) and nuchal ligament (Fig. 5 g). With anti-type VIII 
antibodies there was no immunofluorescence of  aortic intima 
or media despite attempts to "unmask" the tissue by treatment 
with  hyaluronidase,  pepsin,  or  acetic  acid.  Other tissues 
which were also negative for type VIII collagen included lens 
capsule, kidney, lung, skin, and liver. From these results we 
conclude that type VIII collagen is not a structural compo- 
nent of basement  membranes,  nor is  it preferentially as- 
sociated with the vasculature. 
Type VIII collagen was present in cartilage and calvarium, 
as shown in Fig. 6, a-d. Perichondrial immunofluorescence 
was observed around elastic cartilage, but fluorescence was 
not seen within the cartilage matrix (Fig.  6  a).  Digestion 
with hyaluronidase was required to demonstrate the presence 
of type VIII collagen around chondrocytes (Fig. 6 b). This 
collagen was present in fibrillar arrays in the periosteum and 
dura mater (Fig. 6 c), as well as in the calvarium (Fig. 6 d). 
Type VIII was also localized to the perichondrium of carti- 
lage at the epiphysis of the femur (Fig.  7  a) and to areas 
within the cartilage matrix close to the secondary center of 
ossification  (Fig.  7  b).  Hyaluronidase treatment  was  not 
necessary to demonstrate this immunofluorescence. 
The Journal of Cell Biology, Volume  107, 1988  724 Figure 4.  Immunofluorescence of BCE cells in vitro. Ceils were grown on glass coverslips and exposed sequentially to monoclonal or 
aff nity-purified polyclonal antibodies and FITC-conjugated goat anti-rabbit  IgG. The ECM produced by these cells was also examined 
after removal of the cells by brief treatment with Triton X-100. After fixation in cold acetone for 10 min, cells in culture for (,4) 12 and 
(B) 34 d were exposed to monoclonal anti-50,000-Mr polypepfide IgG. Unfixed cells were exposed to (C) anti-type HI procollagen IgG 
and (D) anti-50,000-Mr IgG. The ECM was reacted with (E) anti-type HI procollagen IgG and (F) anti-50,000-Mr IgG. Bar, 50 Ixm. 
Since the immunofluorescence studies indicated that type 
VIII collagen was present in perichondrium, we compared 
the collagens from bovine perichondrium with those of bo- 
vine DM.  Collagens from these tissues were extracted by 
brief pepsin digestion and were partially purified by precipi- 
tation  with  NaC1.  Type V  collagen  and  50,000-Mr  frag- 
ments were present in the extract of DM (Fig.  8, lane 1), 
while the perichondrium contained only type II collagen by 
Coomassie Blue staining of the polyacrylamide gel (Fig. 8, 
lane 2).  Immunoblotting of these fractions with the mAb, 
however, showed a  strong positive reaction with 50,000-Mr 
fragments in both the DM and perichondrium (Fig. 8, lanes 
3 and 4) and no reaction with collagen types V or II. Thus 
by biochemical and immunologic criteria, type VIH collagen 
was present in the perichondrium of fetal and adult cows. 
The dural covering of the optic nerve was positive for type 
VIII collagen; however, the inner meningial lining was nega- 
tive (Fig. 9 a). In the spinal cord, the meninges were stained 
with anti-type VIII mAb.  Additional fine fibers were also 
demonstrated within the white matter, but not the gray mat- 
ter, of the spinal cord (Fig. 9 c). In comparison, fibrillin was 
present throughout the meninges of the optic nerve (Fig. 9 
b). Fibrillin was also apparent in the meninges around the 
spinal cord and in blood vessels within the spinal cord, but 
its distribution was afibrillar (Fig.  9 d). 
Kapoor et  al. Type VIII Collagen Distribution  in Tissues  725 Figure 5.  Distribution of type VIII collagen in fetal calf tissues: comparison to fibrillin. Frozen sections of fetal calf cornea (a and b), 
sclera (c and d), aorta (e and f), and nuchal ligament (g and h) were exposed sequentially to anti-type VIII collagen mAb (a, c, e and 
g) or anti-fibrillin mAb (b, d, f, and h),  and FITC anti-mouse IgG. Bar, 50 l.tm. 
The Journal of Cell Biology, Volume 107, 1988  726 Figure 6.  Distribution of type VIII collagen in cartilage and calvarium. Frozen sections of fetal calf ear cartilage (a and b), periosteum 
and dura mater of calvarium (c), and calvarial interstitium (d) were exposed sequentially to anti-type VIII collagen antibody and FITC 
anti-mouse  IgG. b shows a similar section to a after treatment with hyaluronidase. Bar, 50 ~tm. 
Discussion 
We have used an mAb specific for pepsin-resistant fragments 
of type VIII collagen to identify this protein in a restricted 
number of tissues: DM of the cornea, the sclera, perichon- 
drium and periosteum, cartilage matrix, bone, meninges of 
the central nervous system, and fine fibrils within the white 
matter of the spinal cord.  In addition,  we have used both 
polyclonal and monoclonal antibodies to identify EC2 (chain 
125,000  Mr)  as  the  principal  molecular  mass  form  of 
secreted type VIII collagen. 
Sage et al. had proposed a model for type VIII collagen 
based on the secretion of EC1, EC2, and sometimes EC3 by 
subconfluent cells labeled for <24 h (22, 24). We now show 
that prolonged labeling resulted in a substantial reduction or 
loss of the EC components in RCE and BCE cell culture 
medium and accumulation of a  60,000-Mr protein that did 
not cross react with anti-50,000-Mr  IgG.  Moreover, anti- 
type VIII collagen antibodies specifically recognized EC2 in 
the culture medium of BCE cells labeled for <24 h.  Based 
on pulse-chase data presented by Sage et al.  (24), and the 
recognition of EC2 by polyclonal and monoclonal antibod- 
ies, it would appear that type VIII collagen is primarily syn- 
thesized in the form of EC2. In contrast, Benya and Padilla 
(3) studied confluent RCE cells labeled for prolonged pe- 
riods  in  the presence of serum.  These workers isolated a 
61,000-Mr protein that they identified as type VIII collagen. 
We suggest that this lower molecular mass collagen differs 
from type VIII. 
Our immunohistochemical survey with mAbs to type VIII 
collagen indicated a very restricted distribution for this pro- 
tein.  Although  type VIII collagen is  produced by several 
kinds  of endothelia  in  vitro,  we did  not detect it by im- 
munofluorescence in aorta nor in highly vascularized tissues 
like liver and lung, despite the use of standard procedures for 
unmasking epitopes on collagens (17). Since type VIII colla- 
gen was preferentially recovered from the culture medium of 
rapidly proliferating and/or migrating cells in vitro (20), it 
might only be expressed during the development of the vas- 
culature or in the adult as a result of vascular injury. 
The DM of the cornea is embryologically and ultrastruc- 
turally a unique ECM. Since a major portion of this special- 
ized structure is synthesized by the corneal endothelium, the 
embryonic origin of this cellular population is of consider- 
able interest. Although most studies have been performed in 
avian species (8, 9), it is now generally accepted that the DM 
in both birds and mammals is derived from a population of 
neural crest cells that invades the primary mesenchyme, a 
mesodermal layer surrounding the early optic cup. Collec- 
tively these cells form the secondary mesenchyme, the neu- 
ral crest component of which, in a series of migrations, sub- 
sequently gives  rise to corneal stroma,  endothelium,  and 
other ocular structures (see reference 2 for a review). Recent 
studies with mAbs have supported the hypothesis that the 
corneal endothelial cells are derived from early periocular 
vascular endothelium (6). 
Electron microscopy has shown that the DM is comprised 
of fibers arranged in hexagonal lattices (10, 27). We speculate 
Kapoor et al.  Type VIII Collagen Distribution  in Tissues  727 Figure 7. Occurrence of type VIII collagen in the matrix of carti- 
lage. Frozen sections of fetal calf femur were reacted sequentially 
with anti-type VIII collagen antibody and FITC anti-mouse IgG. 
(a) Epiphysis including perichondrium;  (b) cartilage matrix near 
secondary center of ossification. Bar, 50 Ixm. 
that type VIII collagen contributes to this fibrillar network, 
as Labermeier and Kenney (15) have claimed that a substan- 
tial proportion of the collagen in bovine DM is type VIII. We 
found that  type VIII collagen was  not codistributed with 
types I, III, V, and VI collagen in the corneal stroma but was 
restricted to the DM. The absence of type VIII collagen from 
the area of Bowman's membrane subjacent to the corneal epi- 
thelium, as well as from other BM, suggests that type VIII 
collagen is not immediately associated with type IV collagen 
of the lamina densa. 
Type VIII collagen is also a component of cartilage matrix 
and perichondrium. The embryonic relationship of these tis- 
sues to DM  is,  however, not clear.  The perichondrium is 
populated by osteoprogenitor cells contributing to fibrogenic 
and osteogenic layers, while DM is secreted by fibroblasts 
of the corneal stroma and by the corneal endothelium (8, 9, 
12). Since the development of  both cornea and endochondral 
bone is associated with the transient synthesis of type II col- 
lagen (31), it is possible that expression of  the type II and type 
VIII genes is coregulated during embryogenesis. We are cur- 
rently testing this hypothesis by examining embryonic chicks 
at different developmental stages. 
Our results indicate that type VIII collagen is prevalent in 
mid-gestation fetal calf calvarium. The formation of carti- 
lage and bone from a  neural crest-derived mesenchyme is 
characteristic of skeletal tissues of the head. Studies in vitro 
Figure 8. Analysis of collagens purified from the pepsin-treated bo- 
vine  DM  and  perichondrium.  Samples  were  resolved  on  8% 
SDS-polyacrylamide gels and visualized by staining with Coomas- 
sie Blue (lanes 1 and 2) or autoradiography (lane 3 and 4). Lane 
1, bovine DM; lane 2, perichondrium.  The collagenous proteins 
were transferred from a polyacrylamide gel to nitrocellulose and 
immunoblotted with monoclonal anti-50,000-Mr IgG. Lane 3, bo- 
vine DM (antibody dilution was 1:100); lane 4, bovine perichon- 
drium (antibody dilution was 1:40). Protein molecular mass stan- 
dards (×  10  -3 D) are shown. 
have shown that both chondrogenic differentiation of neural 
crest cells  and  osteogenesis  of neural  crest-derived ecto- 
mesenchyme depend upon interactions of these cells with 
epithelial cells/ECM (7). Thorogood et al. (29) have demon- 
strated a transient expression of type II collagen at epithelio- 
mesenchymal interfaces during formation of the chick car- 
tilaginous neurocranium, which they hypothesize may act as 
a temporal and spatial signal in the ECM for overt chondro- 
genesis. In this context, the appearance of type VIII collagen 
might also be linked to that of type II (or other components 
of the ECM). Since we do not know whether type VIII colla- 
gen is expressed transiently or becomes incorporated into the 
ECM as a permanent structural element, the role of this pro- 
tein in directing cellular migration or interactions cannot be 
ascertained at the present time. 
The meninges of the central nervous system provide an- 
other example of tissue derived from neural crest that is en- 
riched for type VIII collagen (other examples being DM, 
sclera, and calvarium). Although morphological resolution 
in these frozen sections is limited, it is possible that the ap- 
parent staining of the pia mater in the spinal cord could arise 
from the subadjacent glial membrane that is formed from the 
The Journal of Cell Biology, Volume  107, 1988  728 Figure 9. Immunofluorescence  of type VIII collagen in nervous tissue. Frozen sections of fetal calf optic nerve (a and b) and spinal cord 
(c and d) were incubated sequentially with anti-type VIII collagen antibody (a and c) or anti-fibrillin antibody (b and d), and FITC 
anti-mouse IgG. Bar, 50 Ixm. 
processes and terminal enlargements of fibrous astrocytes. 
This observation would be consistent with the heightened 
production of type VIII collagen by astrocytoma cells in cul- 
ture (1). We have also found that cells derived from early 
stage and/or undifferentiated human astrocytomas produced 
type VIII collagen, while those from more advanced stages 
synthesized primarily the interstitial type I collagen (Sage, 
H., and L. Old, unpublished observations). Based on recent 
studies of glial cell progenitors in the developing rat optic 
nerve (28), we predict that type VIII collagen would be pro- 
duced by,  and possibly facilitate the migration of,  type 2 
astrocytes which contribute to the formation of the nodal 
axolemma. 
In the adult, synthesis and assembly of type VIII collagen 
in the ECM may be related to tissue injury as previously sug- 
gested for other collagens and ECM components (13, 19). In 
accordance with conclusions derived from studies in which 
cell  cultures  were  used  (20),  actively proliferating  cells 
would preferentially synthesize type VIII collagen, while this 
gene would not be transcribed by quiescent cells in vivo. In 
the human cornea, there is a significant decline in the num- 
ber of endothelial cells during development ("~45 % between 
0 and 30 yr; 2). Morphologic studies on DM have revealed 
changes in collagen deposition concomitant with terminal 
differentiation  and reorganization of the corneal endothelium 
around the time of  birth (2). It is possible that type VIII colla- 
gen is a product of undifferentiated  or stem cells and that the 
type VIII gene is reactivated during cellular proliferation as 
a result of injury. In this case, understanding the regulation 
of  this collagen may reveal basic mechanisms underlying cel- 
lular differentiation. 
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